ALX Oncology Holdings Inc. (ALXO)

NASDAQ: ALXO · Real-Time Price · USD

2.110

-0.240 (-10.21%)

At close: Feb 27, 2026, 4:00 PM EST

2.030

-0.080 (-3.79%)

After-hours: Feb 27, 2026, 7:25 PM EST

ALX Oncology Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2018
Selling, General & Admin	23.85	26.09	28.48	29.04	23.39	Upgrade
Research & Development	77	116.37	141.8	98.4	60.17	Upgrade
Operating Expenses	100.85	142.47	170.28	127.44	83.56	Upgrade
Operating Income	-100.85	-142.47	-170.28	-127.44	-83.56	Upgrade
Interest Expense	-1.6	-1.73	-1.57	-0.24	-0.01	Upgrade
Interest & Investment Income	3.96	9.37	10.65	4.28	0.09	Upgrade
Other Non Operating Income (Expenses)	-0.04	-0.02	0.39	-0.02	-0.01	Upgrade
EBT Excluding Unusual Items	-98.52	-134.85	-160.81	-123.42	-83.48	Upgrade
Asset Writedown	-3.18	-	-	-	-	Upgrade
Pretax Income	-101.7	-134.85	-160.81	-123.42	-83.48	Upgrade
Income Tax Expense	-	-	-	0.06	-0.02	Upgrade
Net Income	-101.7	-134.85	-160.81	-123.48	-83.46	Upgrade
Net Income to Common	-101.7	-134.85	-160.81	-123.48	-83.46	Upgrade
Shares Outstanding (Basic)	54	52	43	41	40	Upgrade
Shares Outstanding (Diluted)	54	52	43	41	40	Upgrade
Shares Change (YoY)	2.84%	21.37%	5.62%	0.97%	118.05%	Upgrade
EPS (Basic)	-1.90	-2.58	-3.74	-3.03	-2.07	Upgrade
EPS (Diluted)	-1.90	-2.58	-3.74	-3.03	-2.07	Upgrade
Free Cash Flow	-	-122.36	-131.64	-90.65	-68.77	Upgrade
Free Cash Flow Per Share	-	-2.35	-3.06	-2.23	-1.71	Upgrade
EBITDA	-100.11	-141.6	-169.44	-127.09	-83.5	Upgrade
D&A For EBITDA	0.74	0.87	0.84	0.34	0.05	Upgrade
EBIT	-100.85	-142.47	-170.28	-127.44	-83.56	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.